Integrated-omics analysis defines subtypes of hepatocellular carcinoma based on circadian rhythm

  • 0Henan Key Laboratory for Helicobacter pylori and Digestive Tract Microecology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China; Institute of Rehabilitation Medicine, Henan Academy of Innovations in Medical Science, Zhengzhou 450000, Henan Province, China; Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou 450000, Henan Province, China.

|

|

Summary

This summary is machine-generated.

Circadian rhythm disruption (CRD) in hepatocellular carcinoma (HCC) defines three subtypes. Higher CRD scores correlate with worse prognosis, enabling personalized treatment strategies for HCC patients.

Area Of Science

  • Oncology
  • Chronobiology
  • Genomics

Background

  • Circadian rhythm disruption (CRD) is linked to poor prognosis in hepatocellular carcinoma (HCC).
  • The underlying mechanisms of CRD in HCC remain largely undefined.
  • Understanding HCC heterogeneity based on CRD is crucial for improving patient outcomes.

Purpose Of The Study

  • To classify hepatocellular carcinoma (HCC) subtypes based on circadian rhythm disruption (CRD).
  • To explore the molecular and clinical heterogeneity among these defined HCC subtypes.
  • To identify potential biomarkers for predicting prognosis in HCC patients with CRD.

Main Methods

  • Developed the HCC CRD score (HCCcrds) to quantify circadian rhythm disruption.
  • Utilized machine learning to identify CRD module genes and define HCC subtypes.
  • Applied bioinformatics to analyze cellular heterogeneity across identified CRD-related HCC subtypes.

Main Results

  • Identified three distinct HCC subtypes with significant prognostic heterogeneity.
  • High HCCcrds subtypes showed worse prognosis, higher pathological grade, and advanced stages.
  • Low HCCcrds subtypes demonstrated better clinical outcomes, with novel biomarkers identified.

Conclusions

  • Classified HCC patients into three distinct circadian rhythm-based groups with unique biomarkers.
  • Established a correlation between higher HCCcrds and worse prognosis within these subtypes.
  • Proposed a novel approach for improved HCC prognosis prediction and precision treatment guidance.